BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32883514)

  • 21. Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.
    Santoro N; Eisenberg E; Trussell JC; Craig LB; Gracia C; Huang H; Alvero R; Casson P; Christman G; Coutifaris C; Diamond M; Jin S; Legro RS; Robinson RD; Schlaff WD; Zhang H;
    Hum Reprod; 2016 Oct; 31(10):2268-79. PubMed ID: 27402910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
    Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.
    Kuang H; Jin S; Hansen KR; Diamond MP; Coutifaris C; Casson P; Christman G; Alvero R; Huang H; Bates GW; Usadi R; Lucidi S; Baker V; Santoro N; Eisenberg E; Legro RS; Zhang H;
    Hum Reprod; 2015 Sep; 30(9):2222-33. PubMed ID: 26202922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in antimüllerian hormone levels in early pregnancy are associated with preterm birth.
    Stegmann BJ; Santillan M; Leader B; Smith E; Santillan D
    Fertil Steril; 2015 Aug; 104(2):347-55.e3. PubMed ID: 26074093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction.
    Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
    Li Y; Ruan X; Wang H; Li X; Cai G; Du J; Wang L; Zhao Y; Mueck AO
    Fertil Steril; 2018 Apr; 109(4):720-727. PubMed ID: 29525688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia.
    Naver KV; Grinsted J; Larsen SO; Hedley PL; Jørgensen FS; Christiansen M; Nilas L
    BJOG; 2014 Apr; 121(5):575-81. PubMed ID: 24418062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries.
    Rosenfield RL; Wroblewski K; Padmanabhan V; Littlejohn E; Mortensen M; Ehrmann DA
    Fertil Steril; 2012 Jul; 98(1):242-9. PubMed ID: 22541936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term weight change and live birth among women with unexplained infertility and polycystic ovary syndrome undergoing ovulation induction.
    Vitek W; Sun F; Hoeger KM; Santoro N; Diamond MP; Zhang H; Legro RS;
    Fertil Steril; 2020 Nov; 114(5):1032-1039. PubMed ID: 33036790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
    Xi W; Yang Y; Mao H; Zhao X; Liu M; Fu S
    J Ovarian Res; 2016 Feb; 9():3. PubMed ID: 26864649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility.
    Butts SF; Seifer DB; Koelper N; Senapati S; Sammel MD; Hoofnagle AN; Kelly A; Krawetz SA; Santoro N; Zhang H; Diamond MP; Legro RS;
    J Clin Endocrinol Metab; 2019 Feb; 104(2):369-378. PubMed ID: 30085176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome.
    Elmashad AI
    Fertil Steril; 2011 Jun; 95(7):2342-6, 2346.e1. PubMed ID: 21514928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.